Effect of risperidone on sleep in schizophrenia: a comparison with haloperidol (Q43942856)

28 November 2017

title

Effect of risperidone on sleep in schizophrenia: a comparison with haloperidol (English)

1 reference

28 November 2017

0 references

1 reference

3

Shigeto Yamawaki

1 reference

28 November 2017

1

Hidehisa Yamashita

1 reference

28 November 2017

2

Shigeru Morinobu

1 reference

28 November 2017

Jun Horiguchi

4

1 reference

28 November 2017

Masatsugu Nagao

series ordinal

5

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

28 November 2017

1 reference

28 November 2017

volume

109

1 reference

28 November 2017

issue

2

1 reference

28 November 2017

page(s)

137-142

1 reference

Rapid eye movement sleep eye movements in schizophrenia and depression

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900009-4

7 January 2021

Suppression of REM and delta sleep by apomorphine in man: a dopamine mimetic effect

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900009-4

7 January 2021

Differential effects of the new antipsychotic risperidone on sleep and wakefulness in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900009-4

7 January 2021

Functional role of 5-HT2 receptors in the regulation of sleep and wakefulness in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900009-4

7 January 2021

Reduction in paradoxical sleep after L-dopa administration in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900009-4

7 January 2021

Electroencephalographic sleep in young, never-medicated schizophrenics. A comparison with delusional and nondelusional depressives and with healthy controls

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900009-4

7 January 2021

5-Hydroxytryptamine-2 antagonist increases human slow wave sleep

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900009-4

7 January 2021

Effect of prolonged chlorpromazine administration on the sleep of chronic schizophrenics.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900009-4

7 January 2021

meta-Chlorophenylpiperazine decreases slow-wave sleep in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900009-4

7 January 2021

A preliminary study of the effects of nighttime administration of the serotonin agonist, m-CPP, on sleep architecture and behavior in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900009-4

7 January 2021

Effects of clozapine on sleep measures and sleep-associated changes in growth hormone and cortisol in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900009-4

7 January 2021

Effects of antipsychotic treatment on polysomnographic measures in schizophrenia: a replication and extension

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900009-4

7 January 2021

Effects of ritanserin on sleep disturbances of dysthymic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900009-4

7 January 2021

Olanzapine increases slow-wave sleep: evidence for blockade of central 5-HT(2C) receptors in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900009-4

7 January 2021

Dopamine autoreceptor antagonists: effects on sleep-wake activity in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900009-4

7 January 2021

Electroencephalographic sleep abnormalities in schizophrenia. Relationship to positive/negative symptoms and prior neuroleptic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900009-4

7 January 2021

10.1016/S0165-1781(02)00009-4

Identifiers

DOI

1 reference

28 November 2017

1 reference